What This Immunome Sale Signals Ahead of FDA Milestone
When a biotech firm nears a major FDA decision, every insider transaction can feel like a tell. This article dives in...
Focusing on short term investment goals can yield quick financial returns. Discover the right timing for your investment strategy.
27,474 articlesWhen a biotech firm nears a major FDA decision, every insider transaction can feel like a tell. This article dives in...
A large new stake underscores Core Scientific's shift toward data center services. This article breaks down the impli...
Jet fuel has surged 100% since a regional conflict flared, nudging travelers toward domestic getaways. Two Mega-Cap C...
Cava Group bets on fresh growth and better margins, even as the market stays wary. This piece breaks down what could ...
The SpaceX IPO is stirring big hype, but not every spark is a signal to buy. This guide explains the worst reason spa...
As PDD Holdings gears up for its (pdd) 2026 earnings call, investors should focus on growth sustainability, margin pr...
Crypto assets extended a broad sell-off as ETF withdrawals surged and traders priced in heightened risk. Prices retre...
Nvidia CEO Jensen Huang’s remark on AI-proof degrees has sparked a broader debate about job security in an era of rap...
Broadcom posted solid revenue growth and a solid EPS beat, but AI chip guidance disappointed some. This guide breaks ...
Investors are watching Duluth Trading closely as the Q1 2026 earnings cycle begins. This in-depth look breaks down wh...
Warner Bros. Discovery has formally labeled Paramount Skydance’s all-cash bid superior to Netflix’s, kicking off a sh...
CrowdStrike delivered a strong quarter, beating earnings and lifting full-year guidance, and even announced a 4-for-1...